Skip to content

iRadimed IRMD Ratios & Valuation

FY'25FY'24FY'23FY'22
Profitability
Gross margin76.7%-0.2pp76.9%+0.4pp76.5%-0.9pp77.4%+0.8pp
Operating margin31.2%+1.2pp30%-0.6pp30.6%+1.2pp29.3%+5.8pp
Net margin26.8%+0.6pp26.3%0.0pp26.2%+2.2pp24.1%+1.8pp
Returns
Return on equity24.8%+0.5pp24.3%+0.6pp23.7%+6.1pp17.6%+3.6pp
Efficiency
Asset turnover0.8×0.0×0.8×0.0×0.7×+0.1×0.6×+0.1×
Liquidity
Current ratio-0.9×8.8×+4.2×4.7×-4.4×9.1×-2.1×
Per Share
Book value per share$7.36+8.4%$6.79+21.0%$5.61-3.7%$5.83+1.7%
Valuation
Market capitalization$1.21B+63.4%$697.04M+16.4%$599.06M+68.5%$355.5M-37.7%
Price / earnings51.3×+13.8×36.2×+1.4×34.8×+7.1×27.7×-33.4×
Price / sales14×+4.2×9.5×+0.4×9.1×+2.5×6.7×-7.0×
Price / book12.3×+4.1×-0.4×8.4×+3.6×4.8×-3.1×
Dividend yield1.3%+0.2pp2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are iRadimed's profit margins?
iRadimed (IRMD) runs a 76.8% gross margin and a 32.4% operating margin, with a 27.4% net margin.
Where do iRadimed's ratios come from?
Every ratio is computed from iRadimed's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.